Literature DB >> 28560012

RIZ1 negatively regulates ubiquitin-conjugating enzyme E2C/UbcH10 via targeting c-Myc in meningioma.

Zheng Cai1, Yongxiang Zou1, Hongkang Hu1, Chengyin Lu1, Wei Sun1, Lei Jiang1, Guohan Hu1.   

Abstract

RIZ1 has been considered as an important tumor suppressor gene. Our previous studies have already demonstrated that the expression of RIZ1 is closely related to the occurrence and development of meningioma. In addition, we also found that the expression of UbcH10 was related to the pathologic grade of meningioma which also affected the prognosis of these patients. However, we are lack of the understanding of the effect of UbcH10 on cell proliferation, cell apoptosis, cell cycle and other functions in meningioma cells. Besides, the regulation mechanism between RIZ1 and UbcH10 still remains unclear. In this study, we attempted to demonstrated that UbcH10 was a downstream target of RIZ1 and reported that UbcH10 silencing might negatively regulate cell proliferation, migration, invasion and promote apoptosis, which is similar to the cell phenotype that of over expressed RIZ1. Mechanistically, we proved that UbcH10 was a c-Myc target gene and that RIZ1 regulated UbcH10 expression in a c-Myc-dependent manner. For the first time, our study demonstrated that UbcH10 played a key role in the proliferation, metastasis and apoptosis of primary human malignant meningioma cells. In addition, the mechanism of RIZ1 regulating UbcH10 is also clear. Our study can also provide a potential target and new idea for the follow-up molecular intervention in clinical malignant meningiomas.

Entities:  

Keywords:  RIZ1; UbcH10; c-Myc; meningioma

Year:  2017        PMID: 28560012      PMCID: PMC5446544     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  24 in total

1.  Before and after the spindle assembly checkpoint--an APC/C point of view.

Authors:  Armand de Gramont; Olivier Ganier; Orna Cohen-Fix
Journal:  Cell Cycle       Date:  2006-09-15       Impact factor: 4.534

Review 2.  CNS complications of radiotherapy and chemotherapy.

Authors:  Carole Soussain; Damien Ricard; John R Fike; Jean-Jacques Mazeron; Dimitri Psimaras; Jean-Yves Delattre
Journal:  Lancet       Date:  2009-11-07       Impact factor: 79.321

3.  Candidate tumor suppressor RIZ is frequently involved in colorectal carcinogenesis.

Authors:  R B Chadwick; G L Jiang; G A Bennington; B Yuan; C K Johnson; M W Stevens; T H Niemann; P Peltomaki; S Huang; A de la Chapelle
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

4.  Decreased RIZ1 expression but not RIZ2 in hepatoma and suppression of hepatoma tumorigenicity by RIZ1.

Authors:  G l Jiang; L Liu; I M Buyse; D Simon; S Huang
Journal:  Int J Cancer       Date:  1999-11-12       Impact factor: 7.396

Review 5.  The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.

Authors:  David N Louis; Arie Perry; Guido Reifenberger; Andreas von Deimling; Dominique Figarella-Branger; Webster K Cavenee; Hiroko Ohgaki; Otmar D Wiestler; Paul Kleihues; David W Ellison
Journal:  Acta Neuropathol       Date:  2016-05-09       Impact factor: 17.088

6.  Enhanced expression of the sis and c-myc oncogenes in human meningiomas.

Authors:  K Kazumoto; M Tamura; H Hoshino; Y Yuasa
Journal:  J Neurosurg       Date:  1990-05       Impact factor: 5.115

Review 7.  Medical therapies for meningiomas.

Authors:  Patrick Y Wen; Eudocia Quant; Jan Drappatz; Rameen Beroukhim; Andrew D Norden
Journal:  J Neurooncol       Date:  2010-09-04       Impact factor: 4.130

8.  A study of UbcH10 expression and its association with recurrence of meningiomas.

Authors:  Lei Jiang; Tao Wang; Yi Bao; Jun Qian; Xiao-Jun Wu; Guo-Han Hu; Yi-Cheng Lu
Journal:  J Surg Oncol       Date:  2011-11-17       Impact factor: 3.454

9.  A network model of a cooperative genetic landscape in brain tumors.

Authors:  Markus Bredel; Denise M Scholtens; Griffith R Harsh; Claudia Bredel; James P Chandler; Jaclyn J Renfrow; Ajay K Yadav; Hannes Vogel; Adrienne C Scheck; Robert Tibshirani; Branimir I Sikic
Journal:  JAMA       Date:  2009-07-15       Impact factor: 56.272

10.  Classic, atypical, and anaplastic meningioma: three histopathological subtypes of clinical relevance.

Authors:  H Maier; D Ofner; A Hittmair; K Kitz; H Budka
Journal:  J Neurosurg       Date:  1992-10       Impact factor: 5.115

View more
  4 in total

1.  Identification of key genes and pathways associated with resting mast cells in meningioma.

Authors:  Hui Xie; Ce Yuan; Xiao-Hui Ding; Jin-Jiang Li; Zhao-Yang Li; Wei-Cheng Lu
Journal:  BMC Cancer       Date:  2021-11-12       Impact factor: 4.430

Review 2.  Molecular neuropathology of brain-invasive meningiomas.

Authors:  Niklas von Spreckelsen; Christoph Kesseler; Benjamin Brokinkel; Roland Goldbrunner; Arie Perry; Christian Mawrin
Journal:  Brain Pathol       Date:  2022-03       Impact factor: 6.508

Review 3.  Multifaceted Role of PRDM Proteins in Human Cancer.

Authors:  Amelia Casamassimi; Monica Rienzo; Erika Di Zazzo; Anna Sorrentino; Donatella Fiore; Maria Chiara Proto; Bruno Moncharmont; Patrizia Gazzerro; Maurizio Bifulco; Ciro Abbondanza
Journal:  Int J Mol Sci       Date:  2020-04-10       Impact factor: 5.923

Review 4.  UbcH10 a Major Actor in Cancerogenesis and a Potential Tool for Diagnosis and Therapy.

Authors:  Ivan Presta; Fabiana Novellino; Annalidia Donato; Domenico La Torre; Caterina Palleria; Emilio Russo; Natalia Malara; Giuseppe Donato
Journal:  Int J Mol Sci       Date:  2020-03-17       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.